Back
ESSA Pharma Vs. Acasti Pharma Industry Stock Comparison
Buy
71
EPIX
ESSA Pharma
Last Price:
6.50
Seasonality Move:
-21.1%
Buy
51
ACST
Acasti Pharma
Last Price:
2.79
Seasonality Move:
19.61%
Buy
71
ESSA Pharma (EPIX)
is a Buy
Is ESSA Pharma a Buy, Sell or Hold?
- The current ESSA Pharma [EPIX] share price is $6.70. The Score for EPIX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- EPIX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Acasti Pharma (ACST)
is a Buy
Is Acasti Pharma a Buy, Sell or Hold?
- The current Acasti Pharma [ACST] share price is $2.84. The Score for ACST is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ACST is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EPIX Stock Price Chart
What is ESSA Pharma's stock price today?
-
The ESSA Pharma share price today is $6.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EPIX is experiencing slight selling pressure.
ACST Stock Price Chart
What is Acasti Pharma's stock price today?
-
The Acasti Pharma share price today is $2.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACST is experiencing slight selling pressure.
EPIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 41.51 | Sell |
| Chaikin Money Flow: | -2339 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.37 - 7.85) | Sell |
| Bollinger Bands (100): | (6.77 - 9.31) | Sell |
ACST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 37.99 | Sell |
| Chaikin Money Flow: | -22933 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.85 - 3.35) | Sell |
| Bollinger Bands (100): | (2.49 - 3.37) | Sell |
EPIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.6 | Buy |
| 20-day SMA: | 6.86 | Sell |
| 50-day SMA: | 8.03 | Sell |
| 200-day SMA: | 5.89 | Buy |
| 8-day EMA: | 6.72 | Sell |
| 20-day EMA: | 6.96 | Sell |
| 50-day EMA: | 7.56 | Sell |
| 200-day EMA: | 6.45 | Buy |
ACST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.87 | Sell |
| 20-day SMA: | 3.03 | Sell |
| 50-day SMA: | 3.25 | Sell |
| 200-day SMA: | 2.62 | Buy |
| 8-day EMA: | 2.91 | Sell |
| 20-day EMA: | 3.01 | Sell |
| 50-day EMA: | 3.08 | Sell |
| 200-day EMA: | 2.92 | Sell |
ESSA Pharma Earnings Growth & EPIX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.32 per share.
Acasti Pharma Earnings Growth & ACST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.07 per share, an increase this year of $1.16 per share, and an increase next year of $0.34 per share.
ESSA Pharma Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Acasti Pharma Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||